Three-layer heterogeneous network based on the integration of CircRNA information for MiRNA-disease association

Jia Qu1, Shuting Liu1, Han Li1

  • 1Changzhou University, School of Computer Science and Artificial Intelligence, Changzhou, Jiangsu, China.

PubMed

Insights

This study introduces a computational model, TLHNICMDA, to predict disease-microRNA associations. The model effectively identifies potential links, overcoming limitations of traditional biological experiments for complex diseases.

Area of Science:

  • Bioinformatics
  • Computational Biology
  • Genomics

Background:

  • Abnormal microRNA (miRNA) expression is linked to complex diseases.
  • Biological experiments face limitations in identifying disease-miRNA associations.
  • Computational approaches are needed to enhance prediction accuracy.

Purpose of the Study:

  • To develop a novel computational model, TLHNICMDA, for predicting disease-miRNA associations.
  • To integrate circRNA information into a heterogeneous network for improved prediction.
  • To overcome the limitations of experimental methods in identifying disease-miRNA links.

Main Methods:

  • Constructed a three-layer heterogeneous network incorporating disease-miRNA associations, miRNA-circRNA interactions, and similarity data.
  • Employed an update algorithm on the global network to identify potential disease-miRNA associations.
  • Validated the model using global and local leave-one-out cross-validation (LOOCV) and 5-fold cross-validation.

Main Results:

  • Achieved high Area Under the Curve (AUC) values of 0.8795 (global LOOCV) and 0.7774 (local LOOCV).
  • Demonstrated a mean AUC of 0.8777 ± 0.0010 in 5-fold cross-validations.
  • Case studies confirmed the model's utility in predicting disease-miRNA interactions.

Conclusions:

  • TLHNICMDA effectively predicts disease-miRNA associations by integrating diverse biological data.
  • The model offers a valuable computational tool for understanding disease mechanisms.
  • This approach enhances the identification of potential therapeutic targets through miRNA-disease links.